Primary |
Drug Use For Unknown Indication |
100.0% |
|
Talipes |
66.7% |
International Normalised Ratio Increased |
33.3% |
|
Secondary |
Product Used For Unknown Indication |
24.5% |
Drug Use For Unknown Indication |
19.5% |
Pustular Psoriasis |
9.0% |
Hypertension |
6.5% |
Pneumonia |
5.4% |
Bronchitis |
4.7% |
Pyrexia |
4.3% |
Non-hodgkin's Lymphoma |
4.0% |
Diabetes Mellitus |
3.2% |
Cardiac Failure Congestive |
2.2% |
Pain |
2.2% |
Atrial Fibrillation |
1.8% |
Depression |
1.8% |
Myocardial Ischaemia |
1.8% |
Urethritis |
1.8% |
Arthritis |
1.4% |
Blood Pressure Abnormal |
1.4% |
Gout |
1.4% |
Hypercholesterolaemia |
1.4% |
Muscle Spasms |
1.4% |
|
Rhabdomyolysis |
17.1% |
Tachycardia |
12.2% |
Jaundice Cholestatic |
9.8% |
Pneumonia |
7.3% |
Respiratory Failure |
7.3% |
Cytolytic Hepatitis |
4.9% |
Hepatic Enzyme Increased |
4.9% |
Serotonin Syndrome |
4.9% |
Talipes |
4.9% |
Acquired Haemophilia |
2.4% |
Acute Myocardial Infarction |
2.4% |
Alanine Aminotransferase Increased |
2.4% |
Aplastic Anaemia |
2.4% |
Clostridium Difficile Colitis |
2.4% |
Congestive Cardiomyopathy |
2.4% |
Drug Interaction |
2.4% |
Grand Mal Convulsion |
2.4% |
Hypoalbuminaemia |
2.4% |
Infection |
2.4% |
Lung Infiltration |
2.4% |
|
Concomitant |
Drug Use For Unknown Indication |
22.8% |
Hiv Infection |
19.8% |
Product Used For Unknown Indication |
9.5% |
Prophylaxis |
6.9% |
Antifungal Prophylaxis |
4.4% |
Mycobacterium Avium Complex Infection |
4.1% |
Sepsis |
3.6% |
Cancer Pain |
3.3% |
Pneumonia |
3.1% |
Rash |
2.7% |
Infection Prophylaxis |
2.4% |
Cytomegalovirus Infection |
2.3% |
Antiviral Prophylaxis |
2.0% |
Constipation |
2.0% |
Prostate Cancer Metastatic |
2.0% |
Cough |
1.9% |
Nausea |
1.9% |
Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
Prophylaxis Against Graft Versus Host Disease |
1.8% |
Bone Marrow Conditioning Regimen |
1.7% |
|
Vomiting |
20.7% |
Pneumonia |
8.6% |
Sepsis |
7.8% |
Pulmonary Embolism |
6.0% |
Pyrexia |
6.0% |
Meningitis Cryptococcal |
5.2% |
Respiratory Arrest |
5.2% |
Urinary Retention |
5.2% |
Weight Decreased |
4.3% |
Interstitial Lung Disease |
3.4% |
Prostate Cancer |
3.4% |
Renal Failure Acute |
3.4% |
Blood Immunoglobulin E Increased |
2.6% |
Cough |
2.6% |
Onychoclasis |
2.6% |
Osteonecrosis |
2.6% |
Pneumonitis |
2.6% |
Product Quality Issue |
2.6% |
Shock |
2.6% |
Thrombocytopenia |
2.6% |
|
Interacting |
Pneumonia |
15.9% |
Atrial Fibrillation |
14.6% |
Renal Failure Chronic |
9.8% |
Anaemia Haemolytic Autoimmune |
7.3% |
Helicobacter Gastritis |
7.3% |
Gastritis |
6.1% |
Blood Cholesterol |
4.9% |
Hypertension |
4.9% |
Thyroid Disorder |
4.9% |
Ill-defined Disorder |
3.7% |
Neuroborreliosis |
3.7% |
Respiratory Tract Infection |
3.7% |
Bronchitis |
2.4% |
Upper Respiratory Tract Infection |
2.4% |
Urinary Tract Infection |
2.4% |
Hyperlipidaemia |
1.2% |
Hyperprolactinaemia |
1.2% |
Hyperuricaemia |
1.2% |
Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
Transient Ischaemic Attack |
1.2% |
|
Drug Interaction |
27.8% |
Rhabdomyolysis |
22.2% |
Venoocclusive Liver Disease |
16.7% |
Clostridium Difficile Colitis |
11.1% |
Haemorrhage |
5.6% |
Occult Blood Positive |
5.6% |
Raynaud's Phenomenon |
5.6% |
Vomiting |
5.6% |
|